Methotrexate and glucocorticoid use in relation to cross-sectional and longitudinal associations of red blood cell distribution width in patients with rheumatoid arthritis
Yoshifumi Ohashi, Mochihito Suzuki, Yasumori Sobue, Kenya Terabe, Shuji Asai, Shiro Imagama, Nobunori Takahashi · 2026
Read Methotrexate and glucocorticoid use in relation to cross-sectional and longitudinal associations of red blood cell distribution width in patients with rheumatoid arthritis by Yoshifumi Ohashi, Mochihito Suzuki, Yasumori Sobue, Kenya Terabe, Shuji Asai, Shiro Imagama, Nobunori Takahashi (2026) in the Tower of Babel, a free online library of public-domain works preserved in clean, searchable text. No sign-up. The full text is served as a plain-text file at a predictable URL, where text is present: https://antarctic-labs.com/tower-of-babel/pmc-13438793.txt.
Description
Yoshifumi Ohashi and co-authors study what a spread in red blood cell sizes means for rheumatoid arthritis patients and their treatment, in a 2026 paper. Red cell distribution width is a routine blood test value. High values have been linked to inflammation and worse outcomes. How standard arthritis drugs affect it was not clear.
Nearly seven hundred patients were enrolled, and most had values from two straight years. Patients split into normal and high width groups by a set cutoff. The team tied group membership to methotrexate and steroid doses. Year-to-year changes were checked against dose changes. Results clarify whether the marker mirrors disease or drug effects. Rheumatologists gain context for reading this cheap test.
Catalog record
| CREATOR | Yoshifumi Ohashi, Mochihito Suzuki, Yasumori Sobue, Kenya Terabe, Shuji Asai, Shiro Imagama, Nobunori Takahashi |
|---|---|
| YEAR | 2026 |
| COLLECTION | PAPERS |
| FORMAT | TXT |
| FILE SIZE | 34 KB |
| VERSION | 1.0 |
| LICENSE | CC BY 4.0 |
| RIGHTS | CC BY |
| SOURCE | Europe PMC |